Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance use
Conditions
Interventions
Intervention1: Screening and brief intervention: It consist of three phases â?? formative, intervention, and post-intervention process evaluation. The first phase of the study will be done in the Amba
an emphasis on rewards that compete with substance use, a focus on abstinence-oriented norms and models, and attempts to develop self-efficacy and coping skills. The second phase of the study will det
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: ASSIST score in the â??moderate riskâ??. If the participant scores within the moderate-risk range for two or more of the target drugs, the intervention will be focused on the highest-scoring substance or the substance that is of most concern to the participant. Alcohol, in any case, receive the intervention. Inmates who will remain in the prison for at least 6 months following intervention; for under-trial prisoners, it will be decided on the basis of the next date of the court hearing.
Exclusion criteria
Exclusion criteria: Only tobacco use Unable to provide informed consent for cognitive impairment. Not willing to participate in the intervention and for follow-up assessments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To develop the â??enhancedâ?? component of SBIRT 2. Feasibility and acceptability of brief intervention for substance use disorders in prison population 3. Reduction in the ASSIST score by more or equal to 7 points in the intervention arm compared to the control arm.Timepoint: Third and Sixth months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To identify the facilitators and barriers of the uptake of the intervention and to modify the intervention accordingly. 2. Reduction in the frequency of illicit drug use in the intervention arm compared to the control 3. Reduction in frequency of drinking days and heavy drinking days in the intervention arm compared to the control. 4. Reduction of re incarceration 5. Reduction of high-risk behavior. 6. Reduction of overdose risk.Timepoint: 12 months | — |
Countries
India
Contacts
Public ContactDr Debasish Basu
Postgraduate Institute of Medical Education and Research Chandigarh accredited by NAAC
Outcome results
None listed